Home -> Law Blog Directory -> Religion & Law Blogs -> Religion Clause
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Religion & Law
: Religion ClauseDC Circuit Rejects Free Exercise Challenge To DNA Sampling
By Howard M. Friedman
First, the court held that Kammerling need not exhaust administrative remedies, because the Bureau of Prisons had no authority to grant him any relief on this issue. Moving to the merits, the court rejected Kammerling's challenges under the First Amendment and RFRA. As to RFRA, the court concluded that the DNA collection does not burden any exercise of religion by Kammerling-- it does not pressure him to change his behavior. Even if his religious exercise were burdened, the court concluded that the government had a compelling interest in collecting prisoners' DNA. Yesterday's Washington Post reported on the decision.
Full post as published by Religion Clause on December 31, 2008 (boomark / email).
Parody is a Protected Form of Speech
Targets of criticism seek to shut down Internet sites that poke fun
ValueClick
allegedly violated consumer protection laws by promising ‘free’ goods that where not actually free.
Specialty Lamp International
Recalls Counterfeit Circuit Breakers
Oppenheimer ATM-Free New York Municipals
401(k) / ERISA Stock Fraud
Free Speech
Canterbury agrees to pay $60,000 settlement in civil rights lawsuit.
Indianapolis
alleging the city's police are overly aggressive against the homeless in violation of the protection of free speech and unreasonable searches guaranteed in the US Constitution.
TransUnion
Class action credit practices suit offers free credit monitoring services for millions.

Nebraska High Court Rejects Free Exercise Challenge To Newborn Screening Law
Court Rejects Free Exercise Exemption From Law Numbered 666
1st Circuit rejects Dont Ask, Dont Tell challenge
6th Circuit Rejects Amish Challenge to Septic Tank Requirements
Federal Circuit rejects challenge to the validity of the patent for the drug Plavix








